SH3D19 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.22384349718641E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.81549999980868E-08 |
Normal-vs-Stage2 |
1.79050000048697E-07 |
Normal-vs-Stage3 |
2.23250307129774E-11 |
Normal-vs-Stage4 |
7.86848364242587E-12 |
Stage1-vs-Stage2 |
5.634500E-02 |
Stage1-vs-Stage3 |
6.436700E-04 |
Stage1-vs-Stage4 |
7.50280000000325E-05 |
Stage2-vs-Stage3 |
8.222800E-01 |
Stage2-vs-Stage4 |
4.048200E-01 |
Stage3-vs-Stage4 |
4.262000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.39640537916353E-11 |
Normal-vs-AfricanAmerican |
5.88520010502691E-10 |
Normal-vs-Asian |
5.742000E-02 |
Caucasian-vs-AfricanAmerican |
1.591810E-01 |
Caucasian-vs-Asian |
6.071400E-01 |
AfricanAmerican-vs-Asian |
2.287200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.01785246897634E-12 |
Normal-vs-Female |
3.24029999498876E-08 |
Male-vs-Female |
3.147700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.05919999957716E-07 |
Normal-vs-Age(41-60Yrs) |
7.73310000479199E-08 |
Normal-vs-Age(61-80Yrs) |
1.84119386403836E-12 |
Normal-vs-Age(81-100Yrs) |
4.39380000000211E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.520850E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.487200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.973800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.196300E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.623600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.424000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.814400E-01 |
Normal-vs-Grade 2 |
1.33400000001949E-06 |
Normal-vs-Grade 3 |
1.96165306221019E-12 |
Normal-vs-Grade 4 |
1.62891922173003E-12 |
Grade 1-vs-Grade 2 |
2.784200E-01 |
Grade 1-vs-Grade 3 |
1.874170E-02 |
Grade 1-vs-Grade 4 |
3.613900E-04 |
Grade 2-vs-Grade 3 |
5.262300E-03 |
Grade 2-vs-Grade 4 |
1.45709999999077E-06 |
Grade 3-vs-Grade 4 |
1.461680E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
7.65350000000442E-05 |
Normal-vs-ccB subtype |
2.42172948361485E-12 |
ccA subtype-vs-ccB subtype |
3.5975999956861E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.91589999420927E-09 |
Normal-vs-N1 |
9.79949999999619E-05 |
N0-vs-N1 |
3.436600E-01 |
|
|